NVNO insider trading
NasdaqCM HealthcareenVVeno Medical Corp: insider trade history from SEC Form 4 filings.
About enVVeno Medical Corp
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Company website: www.envveno.com
NVNO insider activity at a glance
FilingIQ tracks 23 insider transactions for NVNO in filings since Nov 18, 2021. The most recent transaction is dated Sep 11, 2026.
Across the full history, 10 open-market purchases
and 6 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on NVNO insider trades is 66.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest NVNO Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading NVNO
Frequently asked
- How many insider trades does FilingIQ track for NVNO?
- FilingIQ tracks 23 Form 4 insider transactions for NVNO (enVVeno Medical Corp), covering filings from Nov 18, 2021 onwards. 1 of those are dated within the last 90 days.
- Are NVNO insiders net buyers or net sellers?
- Across the full Form 4 history for NVNO, 10 transactions (43%) were open-market purchases and 6 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does NVNO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is NVNO in?
- enVVeno Medical Corp (NVNO) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $7.21M.
Methodology & sources
Every NVNO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.